Overview
Pearson's syndrome is characterized by refractory sideroblastic anemia, vacuolization of marrow precursors, and exocrine pancreas dysfunction, often associated with large deletions in the mitochondrial genome 1.Diagnosis
Key Diagnostic Criteria: Refractory sideroblastic anemia with ringed sideroblasts in bone marrow smear 1.
Recommended Tests:
- Mitochondrial genome analysis to identify deletions 1.
- Enzyme activity assays 1.
- Histopathological examination of liver for microvesicular steatosis, hemosiderosis, and cirrhosis 1.
- Genetic testing for hemochromatosis gene mutations (C282Y, H63D) 1.Management
First-Line Treatments:
- Blood transfusions for anemia 1.
- Chelation therapy for iron overload 1.
Adjunctive Treatments:
- Pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency 2.
- Management of complications such as liver failure with supportive care 1.Special Populations
Pediatrics: Rapid progression to severe complications like liver cirrhosis within months of birth 1.
Comorbidities: Presence of hemochromatosis gene mutations may exacerbate iron overload 1.Key Recommendations
Perform mitochondrial genome analysis and bone marrow examination for ringed sideroblasts in diagnosing Pearson's syndrome (Evidence: Strong 1).
Evaluate for hemochromatosis gene mutations (C282Y, H63D) to guide iron management strategies (Evidence: Moderate 1).
Initiate chelation therapy early in patients with significant iron overload to prevent organ damage (Evidence: Expert opinion 1).References
1 Krähenbühl S, Kleinle S, Henz S, Leibundgut K, Liechti S, Zimmermann A et al.. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome. Journal of hepatology 1999. link80050-6)
2 Favareto F, Caprino D, Micalizzi C, Rosanda C, Boeri E, Mori PG. New clinical aspects of Pearson's syndrome. Report of three cases. Haematologica 1989. link